06 Jan New year, new trials: Analysis reveals clinical trial activity trends in 2023

A new report by GlobalData previews the upcoming initiations and completions of clinical trials in the new year.

By Urtė Fultinavičiūtė, Clinical Trials Arena

With the start of the new year, GlobalData released a new report providing a glimpse into what to expect in the clinical trial space in 2023. The report reviews clinical trials that are planned to start and complete this year.

GlobalData is the parent company of Clinical Trials Arena.

“This yearly report gives an early snapshot of what 2023 looks like,” says Brooke Wilson, associate director of research and analysis at GlobalData. The data includes planned clinical trials with a start date in 2023 and planned or ongoing trials with an end date in 2023, which were captured on GlobalData’s Clinical Trials Database as of 15 December 2022.

The trials that are set to start or complete this year were analysed and segmented by Phase, sponsor type, geography, therapy area, and indication. Also, this year’s annual report looks at the use of decentralised clinical trials (DCTs) for the first time. Clinical Trials Arena reviews some of the key highlights from the report. Read more …